Look At Analyst Expectations For A Better Read On Stryker Corporation (NYSE: SYK)

    0
    81

    T. Rowe Price Associates, Inc. (I… recently announced the acquisition of new stake in Stryker Corporation (NYSE:SYK). The institutional investor has increased its shareholding in the Healthcare company by 3.88% to 30.0 million shares with purchase of 1.12 million shares. This fresh investment now brings its stake to 8.00% valued currently at $5.41 billion. In addition, Greenleaf Asset Management, Inc. raised its holdings by 0.6 million to 21.74 million shares. And BlackRock Fund Advisors has lifted its position by 0.03% or 5527.0 shares – to 17.11 million shares.

    With over 1.68 million Stryker Corporation (SYK) shares trading Friday and a closing price of $198.83 on the day, the dollar volume was approximately $334.81 million. The shares have shown a positive weekly performance of 2.99% and its price on 07/24/20 gained nearly 1.88%. Currently, there are 374.80M common shares owned by the public and among those 347.47M shares have been available to trade.

    An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 26 analysts who have offered their price forecasts for SYK have a consensus price objective of $202.74. The analysts have set the share’s price value over the next 12 months at a high of $245.00 and a low of $112.00 should the stock experience a downside. Incidentally, analysts’ outlook for the Stryker Corporation stock is 2.10 for the next 12 months. The average price target is 3.8% above its last price level and an upside to the estimated low will see the stock lose -77.53% over that period. But an upside of 18.84% will see the stock hit the forecast high price target while mean target price for the stock is $205.00.

    Insiders at the company have transacted a total of 102 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 49 of these insider trades were purchases, accounting for 317,361 shares. Insider sales of the common stock occurred on 53 occasions, with total insider shares sold totaling 433,932 shares.

    The top 3 mutual fund holders in Stryker Corporation are Vanguard Total Stock Market Index, Vanguard 500 Index Fund, and T Rowe Price Blue Chip Growth Fun. Vanguard Total Stock Market Index owns 9.63 million shares of the company’s stock, all valued at over $1.73 billion. The company bought an additional 0.45 million shares recently to bring their total holdings to about 2.57% of the shares outstanding. Vanguard 500 Index Fund bought 0.11 million shares to see its total holdings expand to 6.69 million shares valued at over $1.21 billion and representing 1.78% of the shares outstanding. T Rowe Price Blue Chip Growth Fun sold -0.12 million shares to bring its total holdings to over 5.69 million shares at a value of $1.03 billion. T Rowe Price Blue Chip Growth Fun now owns shares totaling to 1.52% of the shares outstanding.

    Shares of Stryker Corporation (NYSE: SYK) opened at $194.91, down -$0.25 from a prior closing price of $195.16. However, the script later closed the day at $198.83, up 1.88%. The company’s stock has a 5-day price change of 2.99% and 5.69% over the past three months. SYK shares are trading -5.29% year to date (YTD), with the 12-month market performance down to -6.50% lower. It has a 12-month low price of $124.54 and touched a high of $226.30 over the same period. Currently, 1.68 million shares have been traded, compared to an average intraday trading volume of 1.65 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 8.10%, 5.71%, and 2.16% respectively.

    Institutional ownership of Stryker Corporation (NYSE: SYK) shares accounts for 74.50% of the company’s 374.80M shares outstanding. Mutual fund holders own 36.70%, while other institutional holders and individual stakeholders account for 37.44% and 15.21% respectively.

    It has a market capitalization of $72.14B and a beta (3y monthly) value of 0.84. The stock’s trailing 12-month PE ratio is 34.91, while the earnings-per-share (ttm) stands at $5.70. The company has a PEG of 6.66 and a Quick Ratio of 1.80 with the debt-to-equity ratio at 0.80. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.15% over the week and 2.51% over the month.

    Analysts forecast that Stryker Corporation (SYK) will achieve an EPS of $0.55 for the current quarter, $1.34 for the next quarter and $8.8 for 2021. The lowest estimate earnings-per-share for the quarter is -$0.13 while analysts give the company a high EPS estimate of $1.03. Comparatively, EPS for the current quarter was $1.98 a year ago. Earnings per share for the fiscal year are expected to increase by 4.60%, and 38.11% over the next financial year. EPS should shrink at an annualized rate of 5.24% over the next five years, compared to 32.40% over the past 5-year period.

    If you are looking to buy this stock, then you may note that the average analyst recommendation by 26 brokerage firm advisors rate Stryker Corporation (SYK) as a “Moderate Buy” at a consensus score of 2.10. Specifically, 13 Wall Street analysts polled rate the stock as a buy, while 9 of the 26 advise that investors “hold,” and 2 rated it as a “Sell.”

    Looking at the support for the SYK, a number of firms have released research notes about the stock. Barclays stated their Underweight rating for the stock in a research note on April 13, 2020, with the firm’s price target at $155. Goldman coverage for the Stryker Corporation (SYK) stock in a research note released on April 01, 2020 offered a Sell rating with a price target of $150. Citigroup was of a view on March 05, 2020 that the stock is Buy, while Goldman gave the stock Buy rating on February 13, 2020, issuing a price target of $248. SunTrust on their part issued Hold rating on January 08, 2020.

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here